健赞的董事会正式地拒绝了赛诺菲·安万特敌意收购其公司的消息新鲜出炉，交易观察家们正满腹猜疑。
Fresh off the news that Genzyme's board officially nixed Sanofi-Aventis' hostile bid for the company, deal-watchers are gathering, full of speculation and possibilities.
健赞的董事会正式地拒绝了赛诺菲·安万特敌意收购其公司的消息新鲜出炉，交易观察家们正满腹猜疑。
Fresh off the news that Genzyme's board officially nixed Sanofi-Aventis' hostile bid for the company, deal-watchers are gathering, full of speculation and possibilities.
应用推荐